(Q47149186)

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Toxicological evaluation and risk assessment of chemical mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Goitrogenic activity of cassava (a staple Nigerian food).

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Predictive modeling of a mixture of thyroid hormone disrupting chemicals that affect production and clearance of thyroxine

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Toward less confusing terminology in endocrine disruptor research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Chemical communication threatened by endocrine-disrupting chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Goitrogens in Food and Water

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Rebuttal of "Flawed Experimental Design Reveals the Need for Guidelines Requiring Appropriate Positive Controls in Endocrine Disruption Research" by (Vom Saal 2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Statistical issues in the analysis of low-dose endocrine disruptor data

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

The use of metabolising systems for in vitro testing of endocrine disruptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR).

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

A critique of the use of hormesis in risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Mode of action as a determining factor in additivity models for chemical mixture risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Diverse developmental toxicity of di-n-butyl phthalate in both sexes of rat offspring after maternal exposure during the period from late gestation through lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Bisphenol A prevents the synaptogenic response to estradiol in hippocampus and prefrontal cortex of ovariectomized nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Membrane oestrogen receptor alpha signalling to cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Plasma membrane estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

21 January 2018

Forage plant estrogens

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

The unfolding stories of GPR30, a new membrane-bound estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Risk assessment of endocrine-active compounds in feeds

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

THE OCCURRENCE OF ANTIGOITROUS SUBSTANCES IN PLANTS

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Risks to health and risks to science: the need for a responsible "bioevidential" scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Review of the toxicity of chemical mixtures: Theory, policy, and regulatory practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Endocrine disrupting pesticides: implications for risk assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Hormesis and its place in nonmonotonic dose-response relationships: some scientific reality checks

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Endocrine toxicants with emphasis on human health risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Assessing and managing risks arising from exposure to endocrine-active chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

The Public and Nanotechnology: How Citizens Make Sense of Emerging Technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Statistical power considerations show the endocrine disruptor low-dose issue in a new light

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Resurrecting the Ancestral Steroid Receptor: Ancient Origin of Estrogen Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Deciding which chemical mixtures risk assessment methods work best for what mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Risk communication of endocrine-disrupting chemicals: improving knowledge translation and transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Good laboratory practices are not synonymous with good scientific practices, accurate reporting, or valid data

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

The importance of appropriate controls, animal feed, and animal models in interpreting results from low-dose studies of bisphenol A.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932

Goitrogenic Properties of Linseed

21 January 2018

1 reference

https://api.crossref.org/works/10.2903%2FJ.EFSA.2010.1932